Institutional investors purchased a net $762.6 thousand shares of RMD during the quarter ended September 2017 and now own 65.92% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.7 Million shares of ResMed Inc
SSGA FUNDS MANAGEMENT, INC. Bought 1.2 Million shares of ResMed Inc
CITADEL ADVISORS LLC Bought 540.6 Thousand shares of ResMed Inc